-

NYSE to Suspend Trading in Cloopen Group Holding Limited (RAAS) and Commence Delisting Proceedings

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE” or the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the American depositary shares (the “ADSs”) of Cloopen Group Holding Limited (the “Company”) ─ ticker symbol RAAS ─ from the NYSE. Trading in the Company’s ADSs will be suspended immediately.

NYSE Regulation reached its decision that the Company’s ADSs are not suitable for listing, because the Company is a late filer and has not filed with the Securities and Exchange Commission its annual reports on Form 20-F for the years ended December 31, 2021 and December 31, 2022 and current report on Form 6-K for the half year ended June 30, 2022 (collectively, the “Delayed Filings”). The Company informed the NYSE that it will not be able to complete its Delayed Filings by May 17, 2023, which is the maximum time allowed under Section 802.01E of the NYSE’s Listed Company Manual.

The Company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange. The NYSE will apply to the Securities and Exchange Commission to delist the ADSs upon completion of all applicable procedures, including any appeal by the Company of the NYSE Regulation staff’s decision.

Contacts

Company Contact:
Cloopen Group Holding Limited
Investor Relations
Email: ir@yuntongxun.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

NYSE Regulation


Release Versions

Contacts

Company Contact:
Cloopen Group Holding Limited
Investor Relations
Email: ir@yuntongxun.com

NYSE Contact:
NYSE Communications
PublicRelations-NYSE@ice.com

More News From NYSE Regulation

NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the two securities enumerated below (“Securities”) of Allurion Technologies, Inc. (the “Company”) from the NYSE. NYSE Regulation reached its decision to commence proceedings to delist the Company’s Securities pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company had fallen below the NYSE’s...

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Vicarious Surgical Inc. (the “Company”) — ticker symbol RBOT — from the NYSE. Trading in the Company’s Class A common stock will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s Class A common stock pursuant to Section 802.01B of the NYSE’s Listed Compan...

NYSE to Commence Delisting Proceedings Against Trinseo PLC (TSE)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the ordinary shares of Trinseo PLC (the “Company”) — ticker symbol TSE — from the NYSE. Trading in the Company’s ordinary shares will be suspended immediately. NYSE Regulation reached its decision to delist the Company’s ordinary shares pursuant to Section 802.01B of the NYSE’s Listed Company Manual because the Company...
Back to Newsroom